COVID-19 mRNA Vaccine and Myocarditis
Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfi...
Main Authors: | Balraj Singh, Parminder Kaur, Leon Cedeno, Taulant Brahimi, Prem Patel, Hartaj Virk, Fayez Shamoon, Manesh Bikkina |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-06-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2681 |
Similar Items
-
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01) -
The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study
by: Ortal Tuvali, et al.
Published: (2022-04-01) -
Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01) -
A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
by: Joana Tome, et al.
Published: (2023-04-01) -
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)